Votes: NJ S1590 | 2018-2019 | Regular Session

Bill Title: Prohibits excessive increases in prices charged for essential off-patent and generic prescription drugs and biological products.

Spectrum: Bipartisan Bill

Status: (Introduced - Dead) 2018-02-05 - Introduced in the Senate, Referred to Senate Health, Human Services and Senior Citizens Committee [S1590 Detail]

Text: Latest bill text (Introduced) [HTML]

Voting Records

ChamberVoteDateYeaNayNVAbsTotalResultSourceView
No roll call record information currently on file.
States not producing parsable votes may be available as images in Supplemental Documents.

Social Comments on NJ S1590

feedback